Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia · Delayed Price · Currency is MYR 1.330
+0.040 (3.10%)
At close: Jun 9, 2026
Pharmaniaga Berhad Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Pharmaniaga Berhad stock has a consensus rating of "Buy" and an average price target of RM 0.69. The average 1-year stock price forecast is 48.12% lower than the current stock price, while the lowest is RM 0.23 (-82.71%) and the highest is RM 1.44 (+8.27%).
Price Target: RM 0.69 (-48.12%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pharmaniaga Berhad stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
4.11B
from 3.93B
Increased by 4.55%
Revenue Next Year
4.26B
from 4.11B
Increased by 3.77%
EPS This Year
0.18
from 0.07
Increased by 173.63%
EPS Next Year
0.24
from 0.18
Increased by 31.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MYR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.3B | ||
| Avg | 4.1B | ||
| Low | 3.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.8% | ||
| Avg | 4.6% | ||
| Low | -0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.44 | ||
| Avg | 0.18 | ||
| Low | 0.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 549.3% | ||
| Avg | 173.6% | ||
| Low | -25.4% |